IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 202 filers reported holding IMPAX LABORATORIES INC in Q4 2017. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $30,000 | +114.3% | 1,546 | +100.3% | 0.00% | – |
| Q4 2017 | $14,000 | -99.4% | 772 | -99.4% | 0.00% | -100.0% |
| Q3 2017 | $2,461,000 | +27244.4% | 121,280 | +21752.3% | 0.00% | – |
| Q2 2017 | $9,000 | +80.0% | 555 | +54.2% | 0.00% | – |
| Q1 2017 | $5,000 | +400.0% | 360 | +373.7% | 0.00% | – |
| Q4 2016 | $1,000 | 0.0% | 76 | +26.7% | 0.00% | – |
| Q3 2016 | $1,000 | -91.7% | 60 | -85.6% | 0.00% | – |
| Q2 2016 | $12,000 | -40.0% | 417 | -33.5% | 0.00% | – |
| Q1 2016 | $20,000 | -23.1% | 627 | +2.5% | 0.00% | – |
| Q4 2015 | $26,000 | +18.2% | 612 | 0.0% | 0.00% | – |
| Q3 2015 | $22,000 | -21.4% | 612 | +2.3% | 0.00% | – |
| Q2 2015 | $28,000 | -88.0% | 598 | -88.1% | 0.00% | – |
| Q1 2015 | $234,000 | +3242.9% | 5,020 | +2181.8% | 0.00% | – |
| Q4 2014 | $7,000 | +40.0% | 220 | 0.0% | 0.00% | – |
| Q3 2014 | $5,000 | -28.6% | 220 | 0.0% | 0.00% | – |
| Q2 2014 | $7,000 | +16.7% | 220 | 0.0% | 0.00% | – |
| Q1 2014 | $6,000 | +100.0% | 220 | +58.3% | 0.00% | – |
| Q3 2013 | $3,000 | 0.0% | 139 | 0.0% | 0.00% | – |
| Q2 2013 | $3,000 | – | 139 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 423,161 | $13,406,000 | 7.47% |
| Aravt Global | 2,300,000 | $72,864,000 | 5.43% |
| Slate Path Capital LP | 2,330,000 | $73,814,000 | 5.16% |
| Orbimed Advisors | 6,678,000 | $211,559,000 | 2.02% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Penn Capital Management Company, LLC | 709,045 | $22,463,000 | 0.94% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $7,920,000 | 0.79% |
| NEW AMSTERDAM PARTNERS LLC/NY | 276,169 | $8,749,000 | 0.76% |
| Matarin Capital Management, LLC | 52,932 | $1,676,886,000 | 0.74% |